Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Ozempic) and chronic weight management (as Wegovy)
Deviating from this schedule introduces unknowns and removes the evidence basis for your treatment
[Related Content] In a large real-world study of more than 125,000 adults published in JAMA Network Open , nearly two-thirds of patients using GLP-1s specifically for weight loss discontinued treatment within the first year
Use posted lot documents where available and your laboratory's validated procedures
With caution, the drug is prescribed to children and adolescents, pregnant and lactating women, as well as the elderly
Patients with type 2 diabetes or metabolic syndrome experience migraine rates up to two to three times higher than metabolically healthy controls
